GSK, Moderna Settle Patent Dispute Over Moderna COVID, RSV Shots

British drugmaker GSK has settled lawsuits that accused Moderna’s COVID-19 vaccines Spikevax and mNEXSPIKE and RSV shot mResvia of infringing its patents, the companies said on Oct. 6. Moderna said in a press release that it settled GSK’s patent litigation …

This post was originally published on this site

Skip The Dishes Referral Code

Lawyers Lookup - LawyersLookup.ca